The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

Twenty-five state societies have voiced their support for the proposal, being presented at the 2023 ACR Annual Meeting in D.C. 

“These evidence-based updates should spur more-informed doctor-patient conversations and help providers save more lives," the document's lead author said. 

Artificial intelligence applied to portable breast US can reduce about half of unnecessary referrals for benign lesions, experts wrote in Radiology. 

University Park OBGYN had its accreditation revoked effective in September, with the facility opting not to appeal the ruling, the FDA said.  

The recommendation is based on an analysis of mortality data from 415,000 U.S. women spanning 2011-2020. 

Among vulnerable women with BRCA1/2 mutations, about 14% never received this vital exam after the rejection, MSK researchers reported.

The University Medical Center Mainz recently surveyed radiologists and referrers to gather feedback on the change.